Navigation Links
More than half of Americans doubt US global leadership in 2020

WASHINGTONMarch 14, 2012More than half of likely voters doubt that the United States will be the No. 1 world leader in science, technology and health care by the year 2020, according to a new national public opinion poll commissioned by Research!America. The findings reveal deep concerns among Americans about the country's ability to maintain its world-class status in innovation, research and development before the next decade.

"A lackluster investment in science and innovation is driving fears among Americans about our world dominance in the years ahead," said Research!America Chair and former Illinois Congressman John E. Porter. "These concerns will likely increase unless policy makers take action to avoid serious consequences, such as a major loss of U.S. jobs, business, medical breakthroughs and output in innovation."

Only 23% of Americans consider the U.S. first in medical and health research today. And an overwhelming majority (91%) say it is important for the U.S. to maintain its world leadership role, as other nations such as China and India ramp up their investment.

Americans are especially concerned about funding cuts to medical and health research. Upon hearing that federal spending for medical and health research (after adjusting for inflation) has declined over the past five years, more than half of likely voters (57%) had a negative reaction to the cut in spending. Moreover, 54% think that federal spending for medical and health research should be exempt from across-the-board cuts outlined in the Budget Control Act of 2011.

"With the threat of automatic cuts on the horizon, a significant amount of federally supported research and innovation will be shelved, impacting the pace of scientific discovery in the U.S. and forcing patients to stand aside as other priorities dominate," said Mary Woolley, president and CEO of Research!America. "We simply cannot afford to jeopardize our leadership and settle for second best. Elected officials and candidates must make stronger commitments to sustaining our world-class status in research and innovation."

More than half of likely voters (64%) say they would be more likely to vote for a presidential candidate who supports increased government funding for medical and health research. A vast majority of likely voters also think it is important for presidential and congressional candidates to debate issues relating to science, innovation and health.

Poll highlights include:

  • 58% of Americans do not believe the United States will be a world leader in science and technology in 2020;
  • 53% of Americans do not believe the United States will be a world leader in health care in 2020;
  • 65% of Americans say it's important that the U.S. is a leader in medical and health research.
  • 85% of likely voters are concerned about the impact of a decreased federal investment in research, including the possibility of scientists leaving their profession or moving abroad to countries with a stronger investment in research;
  • 66% of likely voters believe government investment in medical and health research will have an impact on the future of the United States; and
  • Nearly 70% of Americans believe science and math education will have an impact on the future of the United States.


Contact: Angie Antonopoulos

Related biology technology :

1. Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Arent Risk Takers
2. ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes
3. AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nations Number One Killer
4. Americans United for Life: Obamas Disbanding Bioethics Council Raises Troubling Questions
5. What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate
6. Americans Travel to Mexico for Stem Cell Stimulation Therapies and E+ Peptide Cancer Vaccine -- Treatments Not Yet Offered in U.S.
7. Proactive Brain Health Critical as Americans Life Expectancy Reaches All Time High
8. Survey Reveals Paternity Questions Loom for More Than One in 10 Americans
9. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
10. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
11. Forward step in forecasting global warming
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... , November 25, 2015 Studies ... and human plaque and pave the way for more effective ... in cats     --> ... commonly diagnosed health problems in cats, yet relatively little was ... Two collaborative studies have been conducted by researchers from the ...
Breaking Biology Technology:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):